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Results: After 24 weeks of therapy, mean reduction of
HBV-DNA level, the percentage of patients with HBV-DNA
lower than 5 log10 copies/ml and the percentage of patients
with HBV-DNA level decrease of more than 2 log10 copies/ml
in group B were signiﬁcantly higher than those in group A
(P < 0.05, respectively). At the end of 24, 48 and 96 weeks,
the patients in group B had higher rates of undetectable
serum HBV-DNA levels and ALT normalization than those in
group A (46% vs 25%, 74% vs 54.2%, 88% vs 70.8%; 52% vs
31.3%, 66% vs 43.8%, 82% vs 62.5%; P < 0.05, respectively).
HBeAg seroconversion rate was signiﬁcant hihger in group B
than those in group A (48% vs 27.1%, P < 0.05). There was no
evidence of adverse effect in patients treated for up to 96
weeks.
Conclusion: Adefovir dipivoxil is an effective treatment
option for nucleoside-naive patients with HBeAg-positive
chronic hepatitis B, especially for those with high serum ALT
levels at baseline. Adefovir dipivoxil treatment through 96
weeks was well tolerated and resulted in continued beneﬁt
for patients with HBeAg-positive chronic hepatitis B.
doi:10.1016/j.ijid.2010.02.2015
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The relationship between HBV precore region muta-
tion and the variation of T-lymphocyte subpopulations in
chronic HBV-infected individuals with normal liver func-
tion tests
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Background: To investigate peripheral T-lymphocyte sub-
population proﬁle and its correlation with HBV precore
region 1896 mutation in chronic HBV-infected (CHI) individ-
uals with normal liver function tests.
Methods: HBV precore region 1896 mutation and distri-
bution of T-lymphocyte subpopulations in peripheral blood
were measured in CHI individuals with normal liver func-
tion tests. HBV markers were detected with ELISA. Serum
HBV DNA load was assessed with quantitative real-time
polymerase chain reaction. The results of peripheral T-cell
subsets were compared among groups based on HBV pre-
core region 1896 mutation status, HBeAg, age, sex and the
quantities of HBV DNA.
Results: CHI individuals with normal liver function tests
had signiﬁcantly decreased CD4+ cells and CD4+/CD8+ ratio,
and increased CD8+ cells compared with unifected controls,
all with P < 0.01. Comparing with HBV precore region non-
mutation group, the patients with precore mutation had
signiﬁcant decreased CD4+ cells and CD4+/CD8+ ratio and
increased CD8+ cells. Univariate analysis showed a simi-
lar pattern of these parameters was signiﬁcantly associated
with presence of serum HBeAg expression and high viral
load, all with P < 0.05 or 0.01. The presence of HBeAg
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xpression carried by the HBV precore region mutation
ositive group were not signiﬁcant different than those
bserved in HBV precore region mutation negative group.
here is a signiﬁcant difference in the quantities of HBV
NA between the HBV precore region mutation positive
roup and negative group. No obvious differences of T-
ell parameters and presence of precore mutation were
bserved among various age groups and sex groups, all with
> 0.05.
Conclusion: T-lymphocyte impaired balance was signiﬁ-
antly associated with HBV precore region mutation in CHI
ndividuals with normal liver function tests. Which with
BeAg expression and the HBV DNA replication affect each
ther and co-result in lower T-cell immune function and
hronic infection persistent status.
oi:10.1016/j.ijid.2010.02.2016
3.035
atterns of hepatitis A infection by Brazilian regions:
esults of the national household survey 2004—2009
. Ximenes1, C.T. Martelli 2,∗, E. Merchan-Hamman3, U.
ontarroyos4, C. Braga5, R. Moreira6, G.M. Figueiredo7,
.R. Cardoso8, M. Turchi9, G. Coral10, A. Stein10, M.L.
ima11, M. Costa12, L.C. Arraes-Alencar11, D. Crespo13, A.
antos dos Santos14, L. Pereira4
Universidade de Pernambuco, Pernambuco, Brazil
Centro de Pesquisas Aggeu Magalhaes - FIOCRUZ, Recife,
razil
Universidade de Brasilia, Brasilia, Brazil
Universidade Estadual de Pernambuco, Recife, Brazil
Centro de Pesquisas Aggeu Magalhaes - FIOCRUZ, Recife,
ernambuco, Brazil
INSTITUTO ADOLFO LUTZ, São Paulo, SP, Brazil
Secretaria de Estado da Saúde, São Paulo, Brazil
Universidade de São Paulo, São Paulo, Brazil
Federal University of Goias, Goiania, Brazil
0 Santa Casa de Porto Alegre, Porto Alegre, Brazil
1 Universidade Federal de Pernambuco, Recife, Brazil
2 Hospital da Base do DF, Brasilia, Brazil
3 Núcleo de Estudos e Pesquisas em Hepatologia da Amazô-
ia, Belem, Brazil
4 Instituto Bioestatístico de Ciência e Tecnologia., Belem,
razil
Background: Brazil has been classiﬁed as high endemic
ountry and HAV vaccine is not implemented in the routine
mmunization calendar. The objectives were to estimate the
revalence of hepatitis A among children and adolescents
y Brazilian regions and household/contextual risk factors
ssociation. This population-based survey was conducted
etween 2004 and 2009. It was a Ministry of Health and
AHO initiative with the Universities and Public laboratories
ocated in the State capitals.
Methods: A stratiﬁed multistage cluster sampling tech-
ique with probability proportional to size was used to
elect around 6400 individuals aged between 5 and 19
ears residents of the State capitals and the Federal Dis-
rict. The sample was stratiﬁed according to age (5—9
nd 10- to 19-years-old) within each region. Individual-
nd household-level data were collected by home inter-
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iew. Total antibodies to hepatitis A virus were detected
y EIA. Frequencies of HAV infection by region and the
ge distribution of the susceptible population were esti-
ated and odds ratio (95% CI) were calculated using
LLAMM.
Results: The prevalence of hepatitis A infection in the
—9 and 10—19 age-group by region: North (28.7% and
7.5%); Northeast (41.5% and 57.4%); Midwest (32.3 and
6.0%); Federal District (33.8% and 65.1%); Southeast (20.6%
nd 37.7%); South (18.9% and 34.5%). There was increasing
rend for the prevalence of HAV infection with age in all
ites. The curves of susceptible populations differed from
ne area to another. Multilevel modelling showed that depri-
ation/low socio-economic status was associated with HAV
nfection in all regions.
Conclusion: This is the ﬁrst national population-based
urvey to determine prevalence of hepatitis A (HBA) in
ll capital cities showing the shift pattern from high to
ntermediated/ low endemicity. Differences in age trends
f infection were detected among settings. This multilevel
odel allowed for quantiﬁcation of contextual predictors of
epatitis A infection in urban areas. Support: PAHO, Ministry
f Health, CNPq.
oi:10.1016/j.ijid.2010.02.2017
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Background: Describe the epidemiological and clinical
haracteristics in the pediatric patients with Acute Liver
ailure that were attended in the period between 1998 and
009 in the different health institutions in Colombia.
Methods: A transversal study based on the revision of
linical histories and questionnaires carried out in 10 health
nstitutions in 5 Colombian cities; including 2 Centers spe-
ialized in Transplants to evaluate the cases of Fulminant
epatic Failure in patients under the age of 18 years of age
resented between January 1998 and November 2009. FHF
as deﬁned as: 1). The elevation of AST and ALT aminotrans-
erases and/or the elevation of conjugated bilirubin. 2). The
bsence of known chronic hepatic disease. 3). INR > or equal
o 1.5 or PT > or equal to 15 seconds after the administration
f vitamin K, if the patient presents encephalopathy or 4).
n INR > or equal to 2.0 or TP > or equal to 20 seconds after
he administration of vitamin K if encephalopathy is not
resented. 5.) The degree of encephalopathy was stratiﬁed
ccording to age and according to its classiﬁcation.ternational Congress on Infectious Diseases (ICID) Abstracts
Results: 47 clinical histories were revised and 46 sub-
ects were included. The average age was 5.8 years of age
4 months of age — 16 years of age); of which 58.6% corre-
ponded to the female gender; 28.35% (13/46) coming from
ural areas. Jaundice was found in 100% of the subjects upon
ntry and encephalopathy in 76% (35/46). Liver failure was
ortal in 32.6% (15/46), with the average age being 6, 5
ears of age. Infection as a result of the Hepatitis A Virus
as one of the ﬁrst causes of FHF with 32.6% (15/46) as well
s Indeterminate Hepatitis (32.6%) and 15.2% caused by a
oxic reaction to the medications. The greatest proportion
f deaths is associated to Indeterminate Hepatitis due to
he forcefulness of the disease and the limited elements to
nderstand its etiology. 76.6% of the transplant candidates
btained a successful transplant (67%); retransplant was car-
ied out in 2 subjects, one died and the other managed to
urvive.
Conclusion: Acute Liver Failure is a frequent pathology
mong the pediatric ages in Colombia and is caused by the
epatitis A Virus in up to 32.6% of the cases. A high per-
entage of patients need liver transplantation and in some
ases have fatal consequences. Many of these cases are pre-
entable with vaccination.
oi:10.1016/j.ijid.2010.02.2018
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epatitis B seroprevalence and associated factors in preg-
ant women and their couples in 6 Amazonian indigenous
opulations in Peru 2007—2008
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Background: Since 1995, there are reports documenting
igh magnitude of Hepatitis B transmission, but information
bout associated factors is scarce.
Methods: From June 2007 to december 2008 a sero-
revalence study was conducted in 6 Amazonian indigenous
opulations: Shispibo-Konibo, Ashaninka, Kandozi, Shapra,
hayahuita, Matsigenka. Objective: to determine the mag-
itude of Hepatitis B infection, and associated factors.
lood samples and written surveys were obtained. Informed
onsent was obtained from National, Regional and local
ommunity leaders and participants. For Hepatitis B testing,
BsAg and Anti-HBc elisa tests were performed.
Results: 1274 pregnant women and 721 male cou-
les were surveyed. Anti-HBc positive results: 522 women
42.06% [95%CI: 39.30% — 44.87%]) and 377 males
54.09% [IC95%CI: 50.31%—57.84%]). HBsAg were positive for
1/393 Anti-HBc positive women (2.80% [IC95%: 1.41% —
.95%]), and 15/312 Anti-HBc positive males (4.81% [IC95%:
.72%—7.81%]).
Anti-HBc positivity in women was associated to:
